Overview

Comparing Everolimus and Sirolimus in Renal Transplant Recipients

Status:
Unknown status
Trial end date:
2018-05-01
Target enrollment:
Participant gender:
Summary
This study is being done to compare the effectiveness and safety of two different kidney transplant immunosuppression drugs, Zortress (the study drug) and Rapamune (which is used in the current standard immunosuppression regimen).
Phase:
N/A
Details
Lead Sponsor:
Dr.Ronald Pelletier
Collaborator:
Novartis
Treatments:
Everolimus
Sirolimus